SuspendedPhase 3Phase 4ACTRN12611000297921

A Randomized controlled trial comparing Topical use of Mupirocin versus Medihoney for the prevention of infection at Tenckhoff Exit Site in Peritoneal Dialysis Patients

Sponsor

Department of Renal Medicine

Enrollment

380 participants

Start Date

Apr 1, 2011

Study Type

Interventional

Conditions

Peritineal Dialysis patients

Summary

not recruiting

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 80 Yearss

Plain Language Summary

Simplified for easier understanding

This trial compares Mupirocin antibiotic ointment versus Medihoney for preventing infections at the catheter exit site in peritoneal dialysis patients. It is for adults aged 18 to 80 who are on peritoneal dialysis. Patients with recent infections, allergies to honey or mupirocin, or those on long-term antibiotics are excluded.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Once daly application of Topical Medihoney (gauze pad) approximately10 mg ( size of a pea) at Peritoneal dialysis catheter exit site once daily (the medihoney dressing will be changed daily ) compared topical application of small amount Mupirocin using cotton bud to Peritoneal dialysis catheter exit site once daily ( 12 months )

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000297921